FDA Inspection 852340 — Homeolab USA Inc.
The FDA completed an inspection of Homeolab USA Inc. on September 6, 2013 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Montreal (Canada)